Skip to main
DD
DD logo

DD Stock Forecast & Price Target

DD Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 55%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

DuPont de Nemours has demonstrated strong sales growth in its Healthcare & Water business, with organic sales increasing due to robust demand in medical packaging, biopharma, reverse osmosis, and ion exchange. Additionally, the company's focus on enhancing its product vitality index is expected to yield improved pricing and mix over the next several years, supported by new product introductions and volume increases from emerging market investments. Furthermore, the Electronics & Industrial segment stands to benefit from the expanding 5G and IoT landscapes, indicating significant potential for volume growth and a favorable shift in DuPont's market valuation as it continues to position itself as a leading multi-industrial entity.

Bears say

The analysis reveals concerns regarding DuPont de Nemours's stock primarily due to anticipated delays in the realization of synergies from its recent restructuring, which could hinder profitability. Additionally, the company is facing ongoing challenges in the electronics and construction markets, sectors that contribute significantly to its revenue streams. Moreover, the slower recovery in China further exacerbates these issues, signaling potential headwinds for DuPont's financial performance in the near term.

DD has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 55% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DuPont de Nemours (DD) Forecast

Analysts have given DD a Buy based on their latest research and market trends.

According to 11 analysts, DD has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $66.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $66.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DuPont de Nemours (DD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.